Improved understanding and management of COVID-19, a potentially life-threatening disease,
could greatly reduce the threat posed by its etiologic agent, SARS-CoV-2. Toward this end…

Background The efficacy and safety profiles of vaccines against SARS-CoV-2 in patients with
cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (…

Infection and infection-related complications are important causes of death and morbidity
following preterm birth. Despite this risk, there is limited understanding of the development of …

Given the immune system's importance for cancer surveillance and treatment, we have
investigated how it may be affected by SARS-CoV-2 infection of cancer patients. Across some …

Checkpoint inhibition (CPI), particularly that targeting the inhibitory coreceptor programmed
cell death protein 1 (PD-1), has transformed oncology. Although CPI can derepress cancer (…

Background The efficacy and safety profile of vaccines against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) have not been definitively established in …

Person-to-person transmission of SARS-CoV-2 virus has triggered a global emergency
because of its potential to cause life-threatening Covid-19 disease. By comparison to …

Whereas pathogen-specific T and B cells are a primary focus of interest during infectious
disease, we have used COVID-19 to ask whether their emergence comes at a cost of broader B …

In the version of this article initially published online, a statement of support was missing from
the Acknowledgements section. The correct ending of the fourth sentence of that section is …

We recently demonstrated that the major effector function of neonatal CD4+ T cells is to produce
CXCL8, a prototypic cytokine of innate immune cells. In this article, we show that CXCL8 …